← Home / Moderna, Inc. (MRNA)
Stock Analysis
Moderna, Inc. (MRNA)
MRNA
MRNA · Market data
57.92 +6.29%
Track MRNA in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when MRNA price is:
52W Range Position
60%
LOWMIDHIGH
Trend
Mixed
Momentum
Neutral
Updated: 2026-07-31 11:46 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 58.22. Holding above 48.86 keeps the current thesis intact.
⚖️
✓
Fundamentals
Strong / Negative
✓
Price Structure
Mixed
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
48.86
↗
Break Above
Confirmation improves above resistance.
58.22
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 48.86
Recent Company Events
SEC VERIFIED
Latest material filings
JUL
31
●
Financial Results
HIGH
MRNA reports financial results
issued a press release announcing its financial results for the second quarter ended June 30, 2026.
8-K Filing • SEC EDGAR
JUL
8
●
Management / Board
MEDIUM
Moderna Appoints Michael McDonnell to Board of Directors
(NASDAQ: MRNA) today announced the appointment of Michael McDonnell to its Board of Directors, effective July 8, 2026.
8-K Filing • SEC EDGAR
MAY
1
●
Financial Results
HIGH
Moderna Reports First Quarter 2026 Financial Results and Provides Business Updates
Reports first quarter revenue of $0.4 billion, with approximately 80% of revenue from international markets Reports first quarter GAAP net loss of $(1.3) billion and GAAP EPS of $(3.40), including $0.9 billion non-recurring litigation settlement charge Reiterates plan to deliver up to 10% revenue growth and GAAP ope...
8-K Filing • SEC EDGAR
What's Driving MRNA?
📈 Technical recovery is improving
Momentum is Neutral. Watch 58.22 for confirmation and 48.86 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 50.55 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
RSI(14)
45.1
◎
How to read this setup
The next meaningful technical decision is likely to occur between support at 50.55 and resistance at 59.17. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.
Price Chart
MRNA — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-30
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$23.0B
Company size
EV
$21.7B
Debt-adjusted value
P/E
-7.2
Not meaningful
P/S
10.3
Premium
P/B
3.1
Balanced
EV/Sales
9.8
Balanced
EV/EBIT
-6.4
Not meaningful
P/FCF
-14.3
Not meaningful
FCF Yield
-6.97%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Financial context is mixed
Financial conditions require selective monitoring.
↗
Revenue Growth
Strong
●
Profitability
Negative
≈
Cash Flow
Recovering
⚖
Balance Sheet
Strong
💵 Revenue
389.00M
↗ Strong
📈 Net Income
-1.34B
↘ Negative
🧮 EPS (Basic)
-3.40
↘ Negative
Moderna, Inc.
Related Opportunities